Annual Shareholders Equity
-$30.58 M
-$35.81 M-684.78%
31 December 2023
Summary:
Akebia Therapeutics annual stockholders equity is currently -$30.58 million, with the most recent change of -$35.81 million (-684.78%) on 31 December 2023. During the last 3 years, it has fallen by -$278.20 million (-112.35%). AKBA annual shareholders equity is now -104.81% below its all-time high of $635.93 million, reached on 31 December 2018.AKBA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$50.40 M
-$16.65 M-49.32%
30 September 2024
Summary:
Akebia Therapeutics quarterly stockholders equity is currently -$50.40 million, with the most recent change of -$16.65 million (-49.32%) on 30 September 2024. Over the past year, it has dropped by -$10.98 million (-27.85%). AKBA quarterly shareholders equity is now -107.93% below its all-time high of $635.93 million, reached on 31 December 2018.AKBA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKBA Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -684.8% | -27.9% |
| 3 y3 years | -112.3% | -136.8% |
| 5 y5 years | -104.8% | -110.8% |
AKBA Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -112.3% | at low | -136.8% | at low |
| 5 y | 5 years | -104.8% | at low | -110.8% | at low |
| alltime | all time | -104.8% | at low | -107.9% | at low |
Akebia Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$50.40 M(+49.3%) |
| June 2024 | - | -$33.75 M(+23.8%) |
| Mar 2024 | - | -$27.26 M(-10.9%) |
| Dec 2023 | -$30.58 M(-684.8%) | -$30.58 M(-22.4%) |
| Sept 2023 | - | -$39.42 M(+47.1%) |
| June 2023 | - | -$26.81 M(+86.8%) |
| Mar 2023 | - | -$14.35 M(-374.4%) |
| Dec 2022 | $5.23 M(-92.9%) | $5.23 M(-62.2%) |
| Sept 2022 | - | $13.85 M(-77.8%) |
| June 2022 | - | $62.30 M(+138.6%) |
| Mar 2022 | - | $26.12 M(-64.7%) |
| Dec 2021 | $74.01 M(-70.1%) | $74.01 M(-46.0%) |
| Sept 2021 | - | $137.15 M(-21.5%) |
| June 2021 | - | $174.63 M(-18.4%) |
| Mar 2021 | - | $213.89 M(-13.6%) |
| Dec 2020 | $247.62 M(-37.3%) | $247.62 M(-22.1%) |
| Sept 2020 | - | $317.96 M(-14.1%) |
| June 2020 | - | $370.26 M(-6.6%) |
| Mar 2020 | - | $396.36 M(+0.4%) |
| Dec 2019 | $394.76 M | $394.76 M(-15.6%) |
| Sept 2019 | - | $467.56 M(-10.0%) |
| June 2019 | - | $519.36 M(-8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $566.38 M(-10.9%) |
| Dec 2018 | $635.93 M(+418.8%) | $635.93 M(+346.1%) |
| Sept 2018 | - | $142.54 M(-14.1%) |
| June 2018 | - | $165.92 M(-15.8%) |
| Mar 2018 | - | $197.10 M(+60.8%) |
| Dec 2017 | $122.57 M(+79.9%) | $122.57 M(+22.7%) |
| Sept 2017 | - | $99.88 M(+75.2%) |
| June 2017 | - | $57.00 M(+86.2%) |
| Mar 2017 | - | $30.62 M(-55.1%) |
| Dec 2016 | $68.12 M(-48.0%) | $68.12 M(-32.4%) |
| Sept 2016 | - | $100.71 M(-24.4%) |
| June 2016 | - | $133.29 M(-20.5%) |
| Mar 2016 | - | $167.76 M(+28.1%) |
| Dec 2015 | $131.00 M(+25.9%) | $131.00 M(-9.9%) |
| Sept 2015 | - | $145.41 M(-2.9%) |
| June 2015 | - | $149.75 M(+58.3%) |
| Mar 2015 | - | $94.61 M(-9.1%) |
| Dec 2014 | $104.08 M(+238.4%) | $104.08 M(-8.4%) |
| Sept 2014 | - | $113.61 M(-6.5%) |
| June 2014 | - | $121.55 M(-4.9%) |
| Mar 2014 | - | $127.87 M(+315.8%) |
| Dec 2013 | $30.75 M(-1247.8%) | $30.75 M |
| Dec 2012 | -$2.68 M | - |
FAQ
- What is Akebia Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Akebia Therapeutics?
- What is Akebia Therapeutics annual shareholders equity year-on-year change?
- What is Akebia Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly shareholders equity year-on-year change?
What is Akebia Therapeutics annual stockholders equity?
The current annual shareholders equity of AKBA is -$30.58 M
What is the all time high annual shareholders equity for Akebia Therapeutics?
Akebia Therapeutics all-time high annual stockholders equity is $635.93 M
What is Akebia Therapeutics annual shareholders equity year-on-year change?
Over the past year, AKBA annual stockholders equity has changed by -$35.81 M (-684.78%)
What is Akebia Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of AKBA is -$50.40 M
What is the all time high quarterly shareholders equity for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly stockholders equity is $635.93 M
What is Akebia Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, AKBA quarterly stockholders equity has changed by -$10.98 M (-27.85%)